Ekachai Medical Care PCL (BKK: EKH)
Thailand
· Delayed Price · Currency is THB
6.05
-0.05 (-0.82%)
Dec 20, 2024, 3:30 PM ICT
Ekachai Medical Care PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 1,319 | 1,209 | 1,049 | 1,146 | 645.75 | 886.04 | Upgrade
|
Other Revenue | - | - | - | - | - | 19.39 | Upgrade
|
Revenue | 1,319 | 1,209 | 1,049 | 1,146 | 645.75 | 905.43 | Upgrade
|
Revenue Growth (YoY) | 15.33% | 15.27% | -8.54% | 77.52% | -28.68% | 38.38% | Upgrade
|
Cost of Revenue | 720 | 669.22 | 609 | 602.79 | 449.81 | 509.33 | Upgrade
|
Gross Profit | 598.53 | 539.39 | 439.51 | 543.57 | 195.94 | 396.09 | Upgrade
|
Selling, General & Admin | 262.11 | 223.9 | 197.33 | 173.05 | 130.58 | 195.04 | Upgrade
|
Operating Expenses | 262.11 | 223.9 | 197.33 | 173.05 | 130.58 | 195.04 | Upgrade
|
Operating Income | 336.41 | 315.49 | 242.18 | 370.52 | 65.36 | 201.05 | Upgrade
|
Interest Expense | -1.87 | -1.65 | -1.62 | -1.81 | -1.56 | -0 | Upgrade
|
Interest & Investment Income | 38.55 | 26.24 | 17.68 | 1.37 | 2.81 | 5.57 | Upgrade
|
Earnings From Equity Investments | -0.83 | -0.07 | - | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 5.17 | 13.29 | 17.55 | 10.29 | 11.37 | - | Upgrade
|
EBT Excluding Unusual Items | 377.44 | 353.3 | 275.79 | 380.37 | 77.99 | 206.62 | Upgrade
|
Gain (Loss) on Sale of Investments | 19.5 | 19.5 | 409.96 | 44.38 | 1.61 | - | Upgrade
|
Pretax Income | 396.94 | 372.8 | 685.75 | 424.76 | 79.59 | 206.62 | Upgrade
|
Income Tax Expense | 71.61 | 70.58 | 134.86 | 84.25 | 13.81 | 40.54 | Upgrade
|
Earnings From Continuing Operations | 325.32 | 302.22 | 550.89 | 340.51 | 65.78 | 166.08 | Upgrade
|
Minority Interest in Earnings | -8.41 | -4.96 | 0.44 | 4.32 | 6.32 | -5.78 | Upgrade
|
Net Income | 316.91 | 297.26 | 551.32 | 344.83 | 72.1 | 160.3 | Upgrade
|
Net Income to Common | 316.91 | 297.26 | 551.32 | 344.83 | 72.1 | 160.3 | Upgrade
|
Net Income Growth | -42.35% | -46.08% | 59.88% | 378.24% | -55.02% | 36.76% | Upgrade
|
Shares Outstanding (Basic) | 743 | 715 | 677 | 653 | 654 | 656 | Upgrade
|
Shares Outstanding (Diluted) | 768 | 753 | 710 | 657 | 654 | 656 | Upgrade
|
Shares Change (YoY) | 2.52% | 5.92% | 8.22% | 0.40% | -0.26% | - | Upgrade
|
EPS (Basic) | 0.43 | 0.42 | 0.81 | 0.53 | 0.11 | 0.24 | Upgrade
|
EPS (Diluted) | 0.41 | 0.40 | 0.78 | 0.53 | 0.11 | 0.24 | Upgrade
|
EPS Growth | -43.77% | -49.10% | 47.75% | 376.28% | -54.90% | 36.76% | Upgrade
|
Free Cash Flow | 263.89 | 280.81 | 235.31 | 289.36 | 6.2 | 23.74 | Upgrade
|
Free Cash Flow Per Share | 0.34 | 0.37 | 0.33 | 0.44 | 0.01 | 0.04 | Upgrade
|
Dividend Per Share | 0.573 | 0.293 | 0.305 | 0.229 | 0.101 | 0.192 | Upgrade
|
Dividend Growth | 88.02% | -3.91% | 33.13% | 127.21% | -47.61% | 27.28% | Upgrade
|
Gross Margin | 45.39% | 44.63% | 41.92% | 47.42% | 30.34% | 43.75% | Upgrade
|
Operating Margin | 25.51% | 26.10% | 23.10% | 32.32% | 10.12% | 22.21% | Upgrade
|
Profit Margin | 24.04% | 24.60% | 52.58% | 30.08% | 11.17% | 17.70% | Upgrade
|
Free Cash Flow Margin | 20.01% | 23.23% | 22.44% | 25.24% | 0.96% | 2.62% | Upgrade
|
EBITDA | 418.29 | 394.01 | 311.92 | 438.54 | 128.16 | 247.19 | Upgrade
|
EBITDA Margin | 31.72% | 32.60% | 29.75% | 38.26% | 19.85% | 27.30% | Upgrade
|
D&A For EBITDA | 81.88 | 78.52 | 69.74 | 68.03 | 62.8 | 46.14 | Upgrade
|
EBIT | 336.41 | 315.49 | 242.18 | 370.52 | 65.36 | 201.05 | Upgrade
|
EBIT Margin | 25.51% | 26.10% | 23.10% | 32.32% | 10.12% | 22.21% | Upgrade
|
Effective Tax Rate | 18.04% | 18.93% | 19.67% | 19.83% | 17.35% | 19.62% | Upgrade
|
Revenue as Reported | 1,360 | 1,258 | 1,491 | 1,201 | 658.73 | 905.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.